Daniel Kim to Antibodies, Monoclonal
This is a "connection" page, showing publications Daniel Kim has written about Antibodies, Monoclonal.
Connection Strength
0.040
-
Pan CX, Liu M, Lau CB, Lau WC, Kim DY, Saberi SA, Rowley R, Kanwar R, Giobbie-Hurder A, LeBoeuf NR, Nambudiri VE. Histopathological predictors of immune-related adverse events among patients with melanoma treated with immune checkpoint inhibitors. J Am Acad Dermatol. 2024 04; 90(4):826-829.
Score: 0.040